Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone alone versus triamcinolone plus topical captopril for keloids
IRCT20260904070904N1Phase 2Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of triamcinolone and captopril in keloid (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Efficacy, Safety and 2 more. Started Oct 2026; status: recruiting.
02
Drugs
triamcinolonecaptopril
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20260904070904N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260904070904N1.